Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/14787210.2021.1902805 http://scihub22266oqcxt.onion/10.1080/14787210.2021.1902805 33719819!ä!33719819 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 247.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Expert+Rev+Anti+Infect+Ther 2021 ; 19 (10): 1219-1244 Nephropedia Template TP {{tp|p=33719819|t=2021. Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials |pdf=|usr=}}{{33719819}} gab.com Text Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials JO: Expert Rev Anti Infect Ther http://www.kidney.de/pget.php?&tw=1&pmid=33719819 #FOAvip Introduction: Currently, there is no approved therapeutic entity for coronavirus disease 2019 (COVID-19) and clinicians are primarily relying on drug repurposing. However, findings across studies are widely disparate, making it difficult to draw firm conclusions. Since clinicians need accurate evidence to treat COVID-19, this manuscript systematically analyzed the published and ongoing studies evaluating the pharmacological interventions for COVID-19.Areas Covered: A systematic search of observational studies and Clinical Trials on the treatment and prevention of COVID-19 was performed by using various databases from inception to 2 December 2020.Expert Opinion: A total of 460 studies met the inclusion criteria. Of these, 37 were research studies, 386 were ongoing trials, and 37 were completed trials. Anti-virals, steroids, anti-malarial, plasma exchange, and monoclonal antibodies were the most common treatment modalities used alone or in combination in these studies. However, tocilizumab, plasma exchange, and steroids have shown significant improvements in patient's clinical and radiological status. Tocilizumab reported minimum hospital stay of 2 days along with maximum recovery and patient's stability rate. Existing literature demonstrate promising results of tocilizumab, plasma exchange, and steroids among COVID-19 patients. Nevertheless, these studies are accompanied by several methodological disparities which should be considered while interpreting the results. Twit Text FOAVip Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials ????Expert Rev Anti Infect Ther http://www.kidney.de/pget.php?&tw=1&pmid=33719819 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33719819 #FOAvip English Wikipedia <ref>{{Cite pmid|33719819}}</ref> Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials #MMPMID33719819 Bokharee N; Khan YH; Khokhar A; Mallhi TH; Alotaibi NH; Rasheed M Expert Rev Anti Infect Ther 2021[Oct]; 19 (10): 1219-1244 PMID33719819show ga Introduction: Currently, there is no approved therapeutic entity for coronavirus disease 2019 (COVID-19) and clinicians are primarily relying on drug repurposing. However, findings across studies are widely disparate, making it difficult to draw firm conclusions. Since clinicians need accurate evidence to treat COVID-19, this manuscript systematically analyzed the published and ongoing studies evaluating the pharmacological interventions for COVID-19.Areas Covered: A systematic search of observational studies and Clinical Trials on the treatment and prevention of COVID-19 was performed by using various databases from inception to 2 December 2020.Expert Opinion: A total of 460 studies met the inclusion criteria. Of these, 37 were research studies, 386 were ongoing trials, and 37 were completed trials. Anti-virals, steroids, anti-malarial, plasma exchange, and monoclonal antibodies were the most common treatment modalities used alone or in combination in these studies. However, tocilizumab, plasma exchange, and steroids have shown significant improvements in patient's clinical and radiological status. Tocilizumab reported minimum hospital stay of 2 days along with maximum recovery and patient's stability rate. Existing literature demonstrate promising results of tocilizumab, plasma exchange, and steroids among COVID-19 patients. Nevertheless, these studies are accompanied by several methodological disparities which should be considered while interpreting the results. |*COVID-19 Drug Treatment[MESH] |Adenosine Monophosphate/analogs & derivatives/therapeutic use[MESH] |Alanine/analogs & derivatives/therapeutic use[MESH] |Amides/therapeutic use[MESH] |Anti-Inflammatory Agents/*therapeutic use[MESH] |Antibodies, Monoclonal, Humanized/therapeutic use[MESH] |Antimalarials/therapeutic use[MESH] |Antiviral Agents/*therapeutic use[MESH] |COVID-19 Serotherapy[MESH] |COVID-19/mortality/therapy[MESH] |Chloroquine/therapeutic use[MESH] |Clinical Trials as Topic[MESH] |Humans[MESH] |Hydroxychloroquine/therapeutic use[MESH] |Immunization, Passive[MESH] |Indoles/therapeutic use[MESH] |Intensive Care Units[MESH] |Length of Stay[MESH] |Lopinavir/therapeutic use[MESH] |Methylprednisolone/*therapeutic use[MESH] |Observational Studies as Topic[MESH] |Patient Admission/statistics & numerical data[MESH] |Pyrazines/therapeutic use[MESH] |Ritonavir/therapeutic use[MESH] |SARS-CoV-2[MESH]Pharmacological interventions for COVID-19: a systematic review of obs(epmc).pdf DeepDyve Pubget Overpricing